retatrutide triple agonist obesity phase 2 trial Lilly's 3 results: 28.3% body weight loss on highest dose Retatrutide FDA Approval Status 2026:
Pay in 4 interest-free payments of $6.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27




























